Prof. Dr. rer. nat. Müller, Walter E.

Geschäftsführender Direktor, Pharmakologisches Institut f. Naturwissenschaftler, Goethe-Universität Frankfurt am Main

Publications:

Effect of generic switch on pharmacy refill compliance after ramipril patent expiry – a retrospective study using the DAPI database

Treatment duration (persistence) of basal insulin supported oral therapy (BOT) in Type-2 diabetic patients: comparison of insulin glargine with NPH insulin.

Comparison of different ways of calculation (DDD vs. SPC) to determine persistence and compliance with beta blockers in the DAPI database.

Generic switch after ramipril patent expiry is not associated with decreased pharmacy refill compliance: a retrospective study using the DAPI database.

Verbesserung der Therapietreue bei Hypertonikern - eine Aufgabe für den Apotheker

Versorgungsforschung: Persistenz und Compliance bei Antihypertensiva

Persistence under treatment with ramipril

Persistence with basal supported oral therapy - comparison of insulin glargine versus NPH insulin.

Persistence with basal supported oral therapy - comparison of insulin glargine versus NPH insulin.

Pharmacy refill adherence with antidepressants.

Utilizing claims data to assess persistence with antidepressants.

Non-Compliance – das unterschätzte Problem: Neue Möglichkeiten der Erfassung über Datenbankanalysen

Methoden der Datenbank-basierten Persistenz- und Apotheken-basierten Adhärenz-Erfassung am Beispiel von Antihypertensiva

Medication adherence and persistence according to different antihypertensive drug classes: A retrospective cohort study of 255,500 patients

Adherence to antihypertensives: feasibility of two self-report instruments to investigate medication-taking behaviour in German community pharmacies.